Categories: HealthcareNews

Dimagi Presents Collaborative Behavioral Health and MAT Access Strategies at APHA 2024

Public health technology partner will discuss work in Colorado to improve and modernize behavioral health access

CAMBRIDGE, Mass., Oct. 24, 2024 /PRNewswire/ — Dimagi, a technology partner for public and community health, will present outcomes from its ongoing behavioral health (BH) modernization partnership with the state of Colorado at the 2024 American Public Health Association (APHA) conference. Centered on the show’s theme of “Rebuilding Trust in Public Health and Science,” Dimagi will showcase a poster highlighting how it helped Colorado lower admission times for medication assisted treatment (MAT) enrollees from four days to mere minutes:

Amid record high deaths associated with drug overdoses in Colorado, the state’s Behavioral Health Administration (BHA) sought to address this critical issue by creating a portfolio of digital solutions to better support all stakeholders within the state’s behavioral health infrastructure. The BHA partnered with Dimagi to develop a suite of solutions to modernize operations and improve access to MAT and other behavioral healthcare.

At APHA, Dimagi will present a poster case study exploring a cornerstone solution in its technology suite for Colorado: the state’s centralized MAT registry. Attendees can view the poster and learn more about Dimagi’s partnership and BH modernization approach at the poster session.

About Dimagi

Dimagi is a global social enterprise that powers impactful public health work through innovative and scalable digital solutions and services. Founded in 2002 out of MIT and Harvard Medical School’s joint division Health Science Tech, Dimagi is globally recognized as the maker of CommCare, the most widely-deployed digital platform that empowers a range of critical health programs, from public health and behavioral health to infectious disease management and more. CommCare has provided proven, customizable applications to over 3,000 projects worldwide, helping thousands of frontline workers, governments and NGOs deliver care and enable stronger health outcomes in their communities. One of the first Certified B Corporations established in Massachusetts, Dimagi has partnered with 24 states across the U.S. to improve public health initiatives domestically. Learn more at https://dimagi.com/us-health.

View original content to download multimedia:https://www.prnewswire.com/news-releases/dimagi-presents-collaborative-behavioral-health-and-mat-access-strategies-at-apha-2024-302285848.html

SOURCE Dimagi, Inc.

Staff

Recent Posts

Cosmo Enters Scale Up Phase with 104M Revenue, 128M Cash, and Breakout AI and Dermatology Platforms

Ad hoc announcement pursuant to Art. 53 LR 2025 marks a key execution year in…

9 minutes ago

Pre-JPM Investor Pulse Signals 2026 Capital Rotation Toward “AI That Ships,” Admin Cost Takeout, and Differentiated Metabolic Assets With Special-Situations Capital Back in Scope

Preliminary, directional read of planned 88-investor sample indicates heightened proof thresholds (unit economics, reimbursement, outcomes)…

14 hours ago

Best GLP-1 Weight Loss Shot (2026): Direct Meds Reviews Prescription Access Pathways as New GLP-1 Formats Expand

LegitScript-certified telehealth platform publishes consumer analysis as searches for GLP-1 weight loss information reach record…

17 hours ago

Nutri Derma Guard Skin Tag Remover Ingredients Investigated: 2026 Analysis Examines Formulation And Consumer Disclosures

Independent investigation examines castor oil, tea tree oil, and salicylic acid formulation claims in the…

17 hours ago

SleepZee Mouth Guard Legitimacy Examined: 2026 Consumer Analysis Investigates Anti-Snoring Device Claims and Company Transparency

Independent examination investigates SleepZee's moldable customization approach, medical-grade material claims, and manufacturer disclosure practices for…

17 hours ago